Long-term effects of cooling treatment for newborns
Part of Brain & nervous system, Injuries & trauma, Mental health clinical trials.
This study looks at how children who received cooling treatment for brain injury at birth are doing in the long run. It aims to understand the lasting effects of this treatment, which might help doctors improve care for future babies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Born between 2014 and 2018.
- Had whole-body cooling (hypothermia treatment) for moderate or severe neonatal encephalopathy, started within 6 hours of birth and continued for 72 hours.
- No congenital infections (infections present at birth).
- No genetic or metabolic disorders.
- No major brain malformations (like lissencephaly).
- Can have an MRI (no metal implants or severe claustrophobia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether cooling a newborn’s body can help babies with mild brain injury after a difficult birth. It aims to see if cooling improves brain-related outcomes compared with standard care.
This study tests a new way to continuously monitor the body temperature of newborns who are receiving cooling therapy (to protect the brain after birth complications). If your baby is eligible, continuous monitoring may help doctors better manage the cooling treatment and improve care.
This study tests a special, non-invasive sensor (near-infrared light) to help doctors choose the best cooling treatment for some newborns after brain injury. It may improve how well cooling works and how safely it’s managed in the first week of life.
This trial tests whether a liquid form of the medicine sildenafil can help repair brain damage in newborns who had a difficult birth and were treated with cooling. If your baby meets the cooling criteria and has brain injury on an MRI, this study may offer an additional treatment option.
This study tests two different pain medicines (dexmedetomidine and morphine) given to newborns during cooling therapy, which is a treatment to help reduce brain injury. The goal is to see which medicine works better for comfort and safety.
This trial studies whether cooling a newborn's body after a difficult birth helps prevent brain damage. Researchers will track babies treated with this cooling therapy and use brain imaging to see how well it works.
Hear when a new Neonatal Encephalopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.